Author/Authors :
Méndez-Lَpez، نويسنده , , Luis Fernando and Zapata-Benavides، نويسنده , , Pablo and Zavala-Pompa، نويسنده , , Angel and Aguado-Barrera، نويسنده , , Miguel Elيas and Pacheco-Calleros، نويسنده , , Javier and Rodrيguez-Padilla، نويسنده , , Cristina and Cerda-Flores، نويسنده , , Ricardo Martيn and Cortés-Gutiérrez، نويسنده , , Elva Irene and Dلvila-Rodr، نويسنده ,
Abstract :
Background and Aims
ertook this study to compare the expression level of prostate apoptosis response-4 (Par-4) among patient outcome in two groups of women with breast cancer (short and long survival) and two groups without breast cancer (benign lesion and control).
s
luded breast specimens with nonhistological abnormalities (eight samples) as a control group. Semiquantitative and quantitative analysis of immunohistochemical staining by image analysis software were used to study the intensity of Par-4 expression. Both methods produced similar results (p >0.05).
s
nificant expression of Par-4 was observed in normal breast tissue. Benign lesions and breast cancer tissue showed strong nuclear expression of Par-4, predominantly on epithelial cells and specifically in ductal cells. Par-4 expression was lower in myoepithelial cells and there was no appreciable stromal staining. Significantly less Par-4 reactivity was detected in tissue from patients with a short survival compared with patients with benign lesions and those with a long survival.
sions
ndings suggest that a lower expression level of Par-4 is related to an unfavorable prognosis. A larger prospective study of samples of all patient groups with a longer follow-up is needed to validate this finding.